Clinical Trials Logo

Clinical Trial Summary

A new version of the DiAs artificial pancreas (AP) system has been developed in view of wide scale outpatient trials. Denominated as inControl , it includes improved user interface and communication modules while closed-loop algorithms remain similar. During this pilot study, the investigators will evaluate this new version of AP for a two-week period during which the patients will use it for closed-loop insulin delivery 24/7 The main goal is train the clinical team with the new system and collect patient opinions on system acceptance from questionnaires. If this trial is conclusive, a randomized 6-month multicentre study including 240 patients will be initiated. A total of 5 patients will be included in this training study over a 4-week period.

Clinical Trial Description


Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

NCT number NCT02892604
Study type Interventional
Source University Hospital, Montpellier
Contact Eric M RENARD, MD, PhD
Phone 467338382
Status Recruiting
Phase N/A
Start date November 2016
Completion date July 2017

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02837094 - Enhanced Epidermal Antigen Specific Immunotherapy Trial -1 Phase 1
Recruiting NCT02907346 - A Reinforcement Approach to Increase Use of CGM N/A
Recruiting NCT01600924 - Study on the Assessment of Determinants of Muscle and Bone Strength Abnormalities in Diabetes
Enrolling by invitation NCT02914886 - Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS) Phase 4
Enrolling by invitation NCT02750527 - Pediatric Population Screening for Type 1 Diabetes and Familial Hypercholesterolemia in Lower Saxony, Germany
Completed NCT02897557 - Insulet Artificial Pancreas Early Feasibility Study N/A
Completed NCT02855307 - Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes Phase 2
Recruiting NCT02544321 - Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes Phase 2
Active, not recruiting NCT02442544 - Prebiotic Fiber Supplement in T1DM Children Early Phase 1
Active, not recruiting NCT02556398 - Use of Mobile-based Technologies to Improve Diabetes Self-management and Postprandial Glucose Control N/A
Completed NCT02760303 - Reducing Stress in Adolescents and Young Adults With Type 1 Diabetes to Improve Diabetes Care N/A
Not yet recruiting NCT02547337 - Glucose-stimulated Pancreatic Islet and Intestinal Blood Flow in Healthy Subjects and in Type 1 Diabetes N/A
Recruiting NCT02796534 - Prevalence of Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients Treated With Insulin Pump (At1Home) N/A
Completed NCT02225379 - Development and Assessment of Feasibility of Non-invasive Multiple Sensor Hypo-Sense as a Tool for Detection of Hypoglycemia N/A
Completed NCT02829177 - Microalbuminuria and Allopurinol in Type 1 Diabetes Phase 4
Completed NCT02248454 - Insulin Bolus Required for High Fat Foods in Type 1 Diabetes N/A
Withdrawn NCT01762657 - The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes Phase 3
Completed NCT02928016 - Effectiveness of Carbohydrate Counting Method With Mixed Meals N/A
Completed NCT02246582 - Adult Accuracy Study of the Enlite 3 Glucose Sensor N/A
Recruiting NCT01940835 - Role of Intestinal Inflammation in the Pathogenesis of Type 1 Diabetes